Intensity Therapeutics, Inc.INTSNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.05% | +4.61% | +10.68% | +37.60% | +211.82% |
| Weighted Average Shares Diluted Growth | +1.05% | +4.62% | +10.68% | +37.60% | +211.80% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -69.00% | -72.34% | -75.30% | -48.77% | +83.87% |
| Book Value per Share Growth | -82.72% | -78.81% | -96.90% | -70.31% | -16.66% |
| Debt Growth | -6.72% | -12.66% | -16.56% | -17.22% | -18.62% |
| R&D Expense Growth | +59.10% | +9.20% | -22.24% | -56.75% | -27.80% |
| SG&A Expenses Growth | +24.58% | -20.33% | -37.30% | -22.71% | -16.84% |